Vertex Pharmaceuticals Secures Landmark Reimbursement Deal with NHS England for First CRISPR Gene-Edited Therapy

Vertex Pharmaceuticals (Nasdaq: VRTX) announced  a reimbursement agreement with NHS England for eligible transfusion-dependent beta thalassemia (TDT...

August 09, 2024 | Friday | News
C2N Diagnostics and Unilabs Partner to Expand Precivity™ Blood Tests for Alzheimer’s Diagnosis to Over 75 Countries

Partnership Expands Reach of C2N’s Precivity™ Blood Tests in Over 75 Countries to Transform Alzheimer’s Disease Early Diagnosis...

August 08, 2024 | Thursday | News
Novartis' Fabhalta® Receives FDA Accelerated Approval for IgA Nephropathy Treatment

Novartis is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Fabhalta® (iptacopan), a ground...

August 08, 2024 | Thursday | News
Calibre Scientific Acquires Acefesa, a Provider of Laboratory Consumables and Equipment in Spain

Calibre Scientific is pleased to announce the acquisition of ACEFE, S.A.U. (“ACEFESA” or the “Company”), a Barcelona-ba...

August 07, 2024 | Wednesday | News
MSD Announces Positive CHMP Opinion for KEYTRUDA® and Padcev® Combo in Advanced Urothelial Carcinoma

MSD (NYSE: MRK), known as Merck & Co., Inc. in the United States and Canada, today announced that the European Medicines Agency’s Committee for...

July 29, 2024 | Monday | News
European Commission Approves AbbVie’s SKYRIZI® for Treatment of Moderately to Severely Active Ulcerative Colitis

AbbVie announced that the European Commission has approved SKYRIZI® (risankizumab) for the treatment of adult patients with moderately to severely ac...

July 29, 2024 | Monday | News
NOVIO's INO-3107 Achieves EMA Certification for Recurrent Respiratory Papillomatosis Treatment

NOVIO a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related disease...

July 26, 2024 | Friday | News
Touchlight Secures Licensing Deal with GSK for Revolutionary Enzymatic DNA Technology

 Touchlight, an innovation-driven CDMO pioneering enzymatic DNA production to enable the genetic medicine revolution,  announced a license agre...

July 23, 2024 | Tuesday | News
Lario Therapeutics Receives $6 Million Grant from MJFF for Innovative Parkinson’s Disease Research

Award supports preclinical research of Lario’s CaV2.3 calcium channel inhibitors as a novel disease-modifying approach for treatment of Par...

July 23, 2024 | Tuesday | News
Valneva Secures $41.3 Million from CEPI and EU to Expand Access to Chikungunya Vaccine IXCHIQ®

Valneva to receive up to $41.3 million from CEPI and the European Union to expand access to chikungunya vaccine, IXCHIQ® Funding will support clin...

July 22, 2024 | Monday | News
Bristol Myers Squibb's Opdivo® Plus Yervoy® EMA Application Validated for First-Line Treatment of Advanced HCC

Bristol Myers Squibb  announced that the European Medicines Agency (EMA) validated its Type II variation application for Opdivo® (nivolumab) plu...

July 22, 2024 | Monday | News
Catalent Expands Flagship European Clinical Supply Facility in Schorndorf, Germany

Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced it has completed expansion of it...

July 17, 2024 | Wednesday | News
CordenPharma Announces Record €900M Investment to Expand Peptide Platform in US and Europe

CordenPharma is making a record investment of ~€900m over the next 3 years in expanding its peptide platform, both at its Colorado, US site and in...

July 16, 2024 | Tuesday | News
Twist Bioscience Expands High-Throughput Antibody Portfolio with Launch of CHO Cell Line for Faster Turnaround Times

Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starti...

July 11, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close